Skip to content


Molecular Neurodegeneration

Open Access

Erratum to: Network-driven plasma proteomics expose molecular changes in the Alzheimer’s brain

  • Philipp A. Jaeger1, 2, 3Email author,
  • Kurt M. Lucin1, 17,
  • Markus Britschgi1, 18,
  • Badri Vardarajan4,
  • Ruo-Pan Huang5, 6,
  • Elizabeth D. Kirby1,
  • Rachelle Abbey1,
  • Bradley F. Boeve7,
  • Adam L. Boxer8,
  • Lindsay A. Farrer4, 9,
  • NiCole Finch10,
  • Neill R. Graff-Radford11,
  • Elizabeth Head12,
  • Matan Hofree13,
  • Ruochun Huang5, 6,
  • Hudson Johns1,
  • Anna Karydas8,
  • David S. Knopman7,
  • Andrey Loboda14,
  • Eliezer Masliah15,
  • Ramya Narasimhan1,
  • Ronald C. Petersen7,
  • Alexei Podtelezhnikov14,
  • Suraj Pradhan1,
  • Rosa Rademakers10,
  • Chung-Huan Sun1,
  • Steven G. Younkin10,
  • Bruce L. Miller8,
  • Trey Ideker3 and
  • Tony Wyss-Coray1, 16Email author
Molecular Neurodegeneration201611:42

Received: 11 May 2016

Accepted: 12 May 2016

Published: 23 May 2016

The original article was published in Molecular Neurodegeneration 2016 11:31

Unfortunately, after publication of this article [1], it was noticed that the name of Matan Hofree was misspelled. The corrected name can be seen above and the original article has been updated to reflect this change.



Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, USA
Institute of Chemistry and Biochemistry, Free University, Berlin, Germany
Departments of Bioengineering and Medicine, University of California, San Diego, USA
Department of Medicine (Biomedical Genetics), Boston University Schools of Medicine, Boston, USA
RayBiotech, Guangzhou, China
RayBiotech, Norcrosse, USA
Department of Neurology, Mayo Clinic, Rochester, USA
Department of Neurology, University of California San Francisco, San Francisco, USA
Departments of Neurology, Ophthalmology, Genetics and Genomics, Epidemiology, and Biostatistics, Boston University Schools of Medicine and Public Health, Boston, USA
Department of Neuroscience, Mayo Clinic, Jacksonville, USA
Department of Neurology, Mayo Clinic, Jacksonville, USA
Departments of Pharmacology and Nutritional Sciences and Sanders-Brown Center on Aging, University of Kentucky, Lexington, USA
Department of Computer Science and Engineering, University of California, San Diego, USA
Genetics and Pharmacogenomics, Merck Research Laboratories, West Point, USA
Department of Pathology, University of California, San Diego, USA
Center for Tissue Regeneration, Repair and Restoration, VA Palo Alto Health Care System, Palo Alto, USA
Present address: Biology Department, Eastern Connecticut State University, Willimantic, USA
Present address: Roche Pharma Research and Early Development, NORD DTA, Roche Innovation, Center Basel, Basel, Switzerland


  1. Jaeger PA, Lucin KM, Britschgi M, Vardarajan B, Huang R-P, Kirby ED, Abbey R, Boeve BF, Boxer AL, Farrer LA, Finch N, Graff-Radford NR, Head E, Hofree M, Huang R, Johns H, Karydas A, Knopman DS, Loboda A, Masliah E, Narasimhan R, Petersen RC, Podtelezhnikov A, Pradhan S, Rademakers R, Sun C-H, Younkin SG, Miller BL, Ideker T, Wyss-Coray T. Network-driven plasma proteomics expose molecular changes in the Alzheimer’s brain. Mol Neurodegener. 2016;11:31. doi:10.1186/s13024-016-0095-2.


© Jaeger et al. 2016